
Covetrus Investor Relations Material
Latest events

Q1 2022
Covetrus
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Covetrus Inc
Access all reports
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. The company design, manufacture, and sell pharmaceutical products for use in treating various ailments in animals such as horses, dogs and cats. Covetrus Animal Health offers a range of products for animal health markets including United States, Canada, Mexico, Brazil, Argentina and Peru. The company's products include drug therapies for cardiovascular conditions; respiratory disorders; gastrointestinal disease; reproductive disorders; urinary tract diseases; infectious diseases; cancers of the skin and internal organs; dental diseases and hoof care; neurotoxicosis in cattle (lesions); toxicosis and mycotoxicoses in ruminants (vomitoxin); preanesthetic products; antibiotics for poultry; parasiticides and antiparasiticides products for livestock; endectocides for swine and other animals.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
CVET
Country
🇺🇸 United States